My personal opinion is that Pharma companies think this treatment may be too good to be true. That's why I think efficacy will be the crucible. Additionally, the hectic past ten years of Benitec may also add to their discounting. This is just my opinion, but I think once we see efficacy, things will change big time. But we need to get on a major exchange. That's indisputable.
- Forums
- ASX - By Stock
- BLT
- Sanofi Signs Benitec's closest competitor Voyager for $845M
Sanofi Signs Benitec's closest competitor Voyager for $845M, page-6
-
- There are more pages in this discussion • 28 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add BLT (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
LPM
LITHIUM PLUS MINERALS LTD.
Simon Kidston, Non Executive Director
Simon Kidston
Non Executive Director
Previous Video
Next Video
SPONSORED BY The Market Online